@misc{indiciaef2eeb6eafcf4,
  title = {Nucleophosmin mutations lead to abnormal, but reversible, nucleoli architecture and aggregate formation - implications for NPM1-targeting therapies in AML},
  author = {Grundy, M. and Lucken, K. and Xing, X. and Simpson, E. L. and Bayyoomi, A. and Beckett, A. J. and Prior, I. A. and Booth, D. G. and Seedhouse, C. H.},
  year = {2024},
  doi = {10.1101/2024.12.30.630786},
  url = {https://www.biorxiv.org/content/10.1101/2024.12.30.630786v1},
  note = {Source identifier: 10.1101/2024.12.30.630786}
}